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Summary:  Backeround: Thoracoscopy has been used 
throu,q]out this centurv, especially in the treatment of pteural 
disease. The introduction of video-assistance and especially 
desi<,ned instrtnnents such as stapline devices in t992 led to a 
worldwide and enthusiastic application for the tl-eatment of a 
wiriety of thoracic pathologies. 
Methods: This report summarizes our experience gained fi'om 
1013 consecutive VATS procedures performed since 1990 for 
various indications in order to clarify its role for surgery of tho- 
racic pathologies. 
Results: 234 patients underwent VATS for pleural biopsy, 154 
for talcage, 163 for pulmonary wedge resections in order to 
clarify interstitial disease or indetermined nodules, 126 for 
spontaneous pneumothorax, 91 for decortication ofempyema, 
63 for symphatectomy, 55 for biopsy of mediastinal lesions, 29 
for pericardial effusions (fenestration), 25 for lung w)lume re- 
duction surgery, 17 for excision of mediastinal cysts and 12 for 
excision of neurogenic tumors of the posterior mediastinum. 
Conclusions: Our results demonstrate that VATS has gained 
established acceptance I\)r several indications, however, cau- 
tion in application of VATS is clearly indicated for some dis- 
eases, especially ["or thoracic malignancies. 
(Acta Chir. Austriaca 1999; 31:286-291 
M6gHehkeiten und Grenzen  der  V ideothorakoskop ie  
Zusammenfassung: Grundlagen: Tborakoskopische Interven- 
tionen werden seit Beginn dieses Jahrhunderts durchgef/.ihrt, 
insbesondere zur Diagnostik und Therapie pleuraler Erkrankun- 
gen. Die Einfahrung der Videothorakoskopie sowie der endo- 
skopischen Klammernfihapparate 1992 hat zu einer enthusiasti- 
schen Verbreitung dieser Methode zur Behandlung einer Viel- 
zahl yon thorakalen Pathologien geftihrt. 
Methodik: In dieser Studie wird unsere Erfahrung anhand von 
seit 1990 an unserer Institution durchgefahrten, 1013 konsekuti- 
ven Thorakoskopien hinsichtlich Indikation und Resultate dar- 
gestellt, um die Rolle der Videothoraskoskopie ffir verschieden- 
ste thorakale Pathologien klarer zu definieren. 
Ergebnisse: 234 Patienten wurden mittels videoassistierter Tho- 
rakoskopie pleurabiopsiert, in 154 Patienten erfolgte eine Talk- 
pleurodese, in 163 eine Lungenkeilresektion im Hinblick auf 
eine offene Lungenbiopsie oder zur histologischen Aufarbeitung 
eines peripheren Rundherdes, in 126 die thorakoskopische Be- 
handlung eines Spontanpneumothorax. in 9! die Dekortikation 
eines pieuraien Empyems, in 63 eine thorakale Sympathekto- 
mie, in 55 eine Lungenvolumenreduktionstherapie, in 29 Patien- 
ten eine Perikardfenestration, in 17 die Exzision yon mediastina- 
len Zysten und in 12 eine Exzision yon neurogenen Tumoren des 
posterioren Mediastinums. 
Schlul3folgerungen: Unsere Resultate zeigen, dab die videoassi- 
stierte Thorakoskopie mittlerweile in klar akzeptiertes Verfah- 
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ren hinsichtlich verschiedener Indikationen darstellt, wfihrend 
bei anderen lndikationsstellungen, i sbesondere bei Maligno- 
men im Thoraxbereich, die Rolle der Thorakoskopie nocb unge- 
ntigend geklfirt ist. 
Introduction 
Thoracoscopy has been used throughout this century, especially 
in the treatment of pleural diseases. The introduction of video- 
assistance and especially designed instruments such as stapling 
devices in t992 led to a worldwide and enthusiastic application 
for the treatment of a variety of thoracic pathologies. Since 
video-assisted thoracoscopic surgery (VATS) is believed to re- 
sult in less postoperative pain and morbidity than conventional 
accesses, it has quickly become very popular for patients and re- 
ferring physicians, leading to a somewhat uncritical application 
in the field of thoracic surgery. There is no doubt that VATS has 
meanwhile gained established acceptance for several indica- 
tions, however, caution in the application of VATS is clearly in- 
dicated for some diseases, especially for thoracic malignancies. 
One should remember that VATS does not really mean "'mini- 
mally invasive surgery" but in fact "minimal access urgery", in- 
dicating that the procedure within the chest cavity - performed 
by VATS or by a conventional access - should follow the same 
well-established principles. This report summarizes or experi- 
ence gained from 1.013 consecutive VATS procedures per- 
formed since 1990 for various indications (Tab. 1). However, 
since this is at single-institution experience, our reflections may 
not necessarily correspond to those from other groups, espe- 
cially regarding anatomical lung resections and mediastinal stir- 
gery. 
P leura l  diseases 
Pleural biopsy: Histological assessment of pleural diseases is a 
well-established indication for VATS in order to clarify pleural 
affections of unknown origin (3). It is not only helpful to estab- 
lish or exclude malignancy but also to confirm or exclude be- 
nign diseases uch as tuberculosis which is again increasingly 
observed. Mesothelioma is also increasingly recognized in re- 
cent years and multiple specimens of different sites are usually 
required to confirnl the diagnosis in an early stage of disease. 
Since mesothelioma tend to grow through the incision sites, 
postoperative irradiation of the trocar sites is recommended (2). 
Tablel. Indications of 1.013 consecutive patients requiring video- 
assisted thoracoscopic interventions. 
Pleural biopsy 
Talc pteurodesis 
Wedge resections (interstitial disease, nodules) 
Treatment of pneumothorax 
Decortication for empyema 
Symphatectomy 
Biopsy of mediastinal lesions 
Pericardial window 
Lung volume reduction surgery 
Excision of mediastinal cysts 
Excision of neurogenic tumors 
Thoracic duct ligation (chylothorax) 
234 
154 
163 
126 
91 
63 
55 
29 
25 
t7 
12 
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Fi 9. 1, Video-assisted thoracoscopic debridement o/" stage 11 empyema: An incision o/'3 cm is made in the ventral aspect of  a presumed 
thoracotomy line and the operator's finger is introduced into the chest cavi O' to assess the chronici O' of  the empyema (a): fibrin and loculations 
are evacuated under endoscopic vision and the.fibrin peel is dissectedJ?om the surfilce ()/'the lzozt~ (b). 
Talc pleurodesis: Pleurodesis is performed to promote adhe- 
sion formation between the visceral and parietal pleura in pa- 
tients with pteural effusions. It can be accomplished using dif- 
ferent echniques including talc poudrage, chemical pleurodesis, 
mechanical abrasion, and argon beam coagulation (3). Talc 
poudrage has shown excellent results provided that the lung is 
capable to completely expand after ewtcuation of the effusion. 
This has to be ensured by thoracocentesis or insertion of a chest 
tube followed by radiographic ontrol before talcage is per- 
formed. No more than 5 g of talc should be used and talc should 
only be offered to patients with a restricted life expectancy in or- 
der to prevent late sequelae of talc administration. VATS en- 
ables a uniform and equally distributed application of talc within 
the chest cavity under direct vision which does not require dou- 
ble lung intubation. Alternatively, talc slurry may be applied 
through the chest tubes in those patients who do not olerate gen- 
eral anesthesia which is efficient and cost effective in the treat- 
ment of malignant effusions (28). 
Empyema: Pleural empyema is a relevant disease involving a 
large number of patients, with severe and disabling sequelae for 
patients with unrecognized or incorrectly treated isease. As de- 
fined by the American Thoracic Society in 1962, pleural 
empyema may pass from its exudative form through a fibrino- 
purulent phase before becoming organized. As a consequence, 
the treatment must be chosen accordingly. Since 1992, we have 
adopted a standardized technique using VATS debridement for 
stage II empyema (24). Enrollment criterias were systemic signs 
of infection (fever, weight loss, pain) with loculated pleural ef- 
fusions consistent with empyema on CT-scau or positive bacte- 
rial cultures at thoracocentesis, and a history of less than 3 weeks 
after onset of fever or pleural effusion. A VATS approach was 
offered to patients fulfilling the enrollment criteria and consent 
was obtained from all patients to proceed to decortication via 
thoracotomy if the empyema was judged to be chronic. After 
double lumen intubation, a standard posterolateral incision was 
drawn on the skin of the patient placed in lateral position. An in- 
cision of 3 cm was made in the ventral aspect of this line and the 
operator's index finger was introduced into the thoracic cavity 
(Fig. 1 a). This digital exploration was found to be helpful in as- 
sessing the chronicity of the empyema; a rigid and narrowed in- 
tercostal space as well as a thick and stiff peel between the lung 
and chest wall were signs of chronicity usually inaccessible to a 
VATS approach. Adhesions between the lung and the chest wall 
were broken and the pleural space was circumferentially freed 
by dissection using the index finger and a suction device, The 
optic was inserted several centimeters apart from this initial inci- 
sion and fluid, loculations and septa were removed by suction 
under endoscopic ontrol. The lung was freed from the chest 
wall with special attention directed to complete debridement of 
the costodiaphragmatic sulcus. The instruments were inserted 
throu-h the initi:d incision without using trocars. This allowed 
for quick and efficient removal of debris and fibrin deposits. 
Visceral decortication was performed by use of a dissector while 
holding the hmg (or the peel) by a duval tk)rceps inserted through 
an additional port (Fig. I b). If VATS was judged unrewarding 
during the operation a standard posterolateral thoracotomy was 
performed (which included the 2 previously performed inci- 
sions) followed by decortication. 135 consecutive patients were 
operated for stage 1I and 111 empyema t our institution between 
1992 to 1998. In 91 patients a VATS approach was chosen and 
in 58 patients the procedure could be accomplished while in 33 
patients a conversion thoracotomy with decortication was per- 
formed. The mortality rate of the whole series was 4.5 %, the re- 
currence rate requiring a 2nd procedure was 0 after open 
decortication, and 3.6 % after VATS debridement. The mean du- 
ration of chest tube drainage and hospitalization after VATS 
debridement and open decortication were 4.1 and 6.4 days, and 
12.3 and 15.1 days, respectively. Postoperative spirometry 6 
months after VATS debridement revealed a mean postoperative 
VC of 84.8 _+ 14.9 % predicted (range 37 % to 112 %). In 52 % 
of the patients VC was > 90 % predicted. The mean FEV 1 was 
88.6 _+ 19.2 % predicted ranging from 36 % to 113 %. In 69 % of 
the patients FEVI was > 90 % predicted. The worst results were 
obtained in the 2 patients after reoperation for recurrent 
empyema with a FEV 1 after the 2rid operation of 34 % and 45 % 
predicted, respectively. VATS is a sate and useful tool in the 
treatment of fibrinopurulent empyema with loculations failing to 
respond to closed chest tube drainage and antibiotics. However, 
failure of recognizing the limits of VATS in the treatment of 
empyema might result in recurrence and poor outcome with re- 
spect to pulmonary function. Open decortication should be per- 
formed liberally if the degree of chronicity is judged to be too far 
advanced and this should be done during the same operation if 
required. Finger palpation with assessment of the narrowing and 
rigidity of the intercostal space, the thickness of the underlying 
pleural peel and the degree of adherence of the lung to the chest 
wall was found especially helpful to determine whether or not 
VATS debridement may be successfully used, and this often 
avoided a lengthy and fruitless VATS attempt. 
VATS was found to be also very helpful for evacuation of a 
persistent hemothorax after interventions and chest trauma (19). 
Clotted blood may be present leading to occlusion of chest tubes 
and is therefore not amenable to drainage. These clots are easily 
removed under VATS guidance with prevention of trapped lung 
and fibrothorax. In contrast, acute and severe hemorrhage into 
the chest after chest trauma usually requires immediate mer- 
gency thoracotomy in order to gain quick hemostasis and pre- 
vent exsanguination. 
Per icardiat  windl~w: Chronic or recurrent pericardiat effu- 
sions are often related to underlying malignant disease such as 
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Fig.  2. Vi~le~-cl`~s~is.ted p ri~`clr~licll~`e1~e~s~tr~zti~)n., tlze l)eric.clr~lit~1n is` g rc l . r~ l  c~il~l i1lc~i.~`~l ~it1l s~.i`s`.s~)rs~ ( cl )~ clI7cl ~l ~i1z~l~t~ c~f.4 x 4 c.1~I i~s~ c.r~t~,~l ( l~ ). 
lung and breast cancer and malignant lymphoma. However, 
50 % of pericardial effusions in patients with known malignan- 
cies are benign. Since survival is significantly better in these pa- 
tients than in those with malignant effusions, diagnosis in these 
situations is essential. Moreover, pericardial effusions may be 
related to other diseases such as infections, post-irradiation 
sequelae, uraemia, collagenoses and myocardial infarction. In a 
substantial number of patients concurrent pleural pathology is 
present requiring a simultaneous pleuropericardial diagnosis. 
Approximately half of the patients uffering from pericardial el:- 
fusions present with symptoms of cardiac tamponade. In these 
situations relief of symptoms by means of pericardial decom- 
pression is required irrespective of the underlying cause. While 
percutaneous catheter drainage and balloon pericardiotomy are
increasingly performed for diagnostic and therapeutic purposes, 
recurrent or loculated effusions are best managed surgically with 
a pericardial window. Video-assisted thoracoscopic pericardial 
fenestration has demonstrated usefulness in this respect since 
this technique affords the opportunity to create a pericardial win- 
dow of sufficient size. Since 1992, pericardial fenestration has 
been offered by use of VATS at our institution to patients with 
recurrent or symptomatic pericardial effusions and with effu- 
sions of unknown origin (10). Inclusion criteria consisted of 
echocardiographically documented pericardial effusions requir- 
ing further diagnosis or relief of symptoms of tamponade and 
persistent or recurrent effusions alter percutaneous drainage and 
balloon pericardiotomy. Exclusion criteria consisted of echo- 
cardiographic or radiological signs of constrictive pericarditis, 
and pericardial tamponade due to previous cardiac surgery or 
blunt and penetrating chest rauma. A CT scan was performed in 
order to identify additional pleural pathology and to determine 
the site of intervention. The scope was inserted through the 5th 
intercostal space at the anterior axillary line and 2 additional 
thoracoports were placed in the 6th intercostal space. Any con- 
comitant pleural effusion was evacuated and pleural pathology 
was biopsied. A pericardiocentesis was performed under direct 
vision and the fluid collected for cytological and microbiologi- 
cal analysis. The pericardium was grasped with a thoracoscopic 
Duval forceps and incised with curved thoracoscopic Metzen- 
baum scissors (Fig. 2 a). Loculations and septa were broken and 
the heart circumferentially freed with a thoracoscopic Senning 
suction device. A pericardial window was created with a mini- 
mum size of 4 x 4 cm while carefully protecting the phrenic 
nerve (Fig. 2 b). In situations with a combined malignant 
pericardial and pleural effusion, talc was applied under direct vi- 
sion on the pleural dome, the chest wall and the diaphragm but 
not ,,~n the mediastinal part of the chest cavity. A chest tube was 
inserted through one of the thoracoport sites into the chest cavity 
with no attempt to drain the pericardium. 29 patients underwent 
thoracoscopic pericardial fenestration since 1992. Histological, 
cytological and lnicrobiological examinations of the samples re- 
vealed inflammation in 33 % of the patients, malignancy in 
29 %, uraemia in 17 % and post-irradiation sequelae in 13 %. 
Additional talc pleurodesis was performed in 25 % of the pa- 
tients suffering from a concomitant malignant pleural effusion. 
There was no treatment related 30-day mortality but 2 patients 
(8 %) died due to progression of malignancy. Follow-up 3 
months after the operation revealed relief of symptoms in all sur- 
viving patients but echocardiography showed a recurrent peri- 
cardial efl:usion in one patient suffering from viral inlection 
which was asymptomatic and without hemodynamic signifi- 
cance. No recurrence was observed in patients having undergone 
talc pleurodesis for concomitant malignant pleural effusion. We 
found VATS well suited for pericardial fenestration, especially 
for loculated efft, sions, recurrent effusions after previously per- 
formed percutaneous catheter drainage manoeuvres and effu- 
sions with additional pleural disease. 
Lung  diseases 
Lung biopsy: VATS has become a true ahernative to open tho- 
racotomy for the diagnosis of diffuse infiltrative lung disease 
(17). This may result in decreased morbidity as compared to 
conventional procedures for patients requiring pulmonary wed- 
,,e resections and allows at the same time a more throughout ex- 
ploration of the entire chest cavity than does a limited thoracoto- 
my. However. single lung ventilation is required for VATS- 
guided wedge resections. Ventilated patients with diffuse lung 
disease requiring a biopsy are therefore still best accessed by a 
small anterolateral thoracotomy for this purpose. Wedge resec- 
tions by use of stapling devices are now preferred over pinch 
biopsies ince histological diagnosis might be difficult to obtain 
in diffuse interstitial lung diseases, and large samples of repre- 
sentative areas are therefore mandatory. Moreover, prolonged 
air leaks are less likely after stapling than after "pinch" biopsy 
techniques. 
~ndeterminate periphera~ pulmonary nodune: VATS has 
become the preferred method for excisionat biopsy of indetermi- 
nate peripheral pulmonary nodules. The term peripheral pulmo- 
nary nodule is used to define spherical esions surrounded by 
lung parenchyma measuring less than 3 cm in diameter (17). A 
variety of parenchymatous pathologies, both benign and malig- 
nant may present as pulmonary nodules and may require histo- 
logical confirmation. Radiological characteristics of "benignity" 
are often moot and the majority of patients and referring physi- 
cian are no longer willing to accept a "watch and wait" policy 
since the introduction of VATS. Transthoracic CT-guided nee- 
dle aspiration biopsy may be a valid alternative to confirm ma- 
lignancy in situations where metastatic lesions are svspected, 
e.~.o in patients with a history of malignancy presenting a new 
lung nodule at lbllow-up. However. its diagnostic accuracy for 
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Fig. 3. Resection of a neurogenic tumor by use of VA'I S in an adult patient ( a), after exclusion qf extensio~ within the spilzal channel (dumbbell tu- 
mor) by use o['a pre-operative MRI (b). 
benign lesions is as low as 50 %. Candidate puhnonary nodules 
for thoracoscopic resection are noncalcified lesions less than 
3 cm in diameter located in the outer 3rd of the lung parenchyma 
or near a fissure with absence of endobronchial extension ( l 7). 
Several techniques have been described to improve the identifi- 
cation for the lesions during operation, including preoperative 
CT hook wire localization or intraoperative ultrasonic examina- 
tion. However, total collapse of the lung and increasing experi- 
ence with instrumental palpation of the parenchyma facilitates 
identification of most subpleural esions. All excised nodules 
should be extracted by use of an Endobag device to prevent u- 
mor implantation at the trocar sites. 
Pneumothorax:  Both, primary and secondary pneumothorac- 
es are well recognized entities lk)r a VATS approach. Blebs and 
bullae are probably better localized and identified by use of 
VATS (with its panoramic view of the entire chest cavity) than 
by a key-hole view through a small axillary thoracotomy. The le-
sions are resected by wedge resection using stapling devices for  
lowed by a pleurectonay of the apex or a mechanical abrasion of 
the parietal pleura by use of a sponge or a piece of surgicos. 
Most centers now perform an abrasion instead of a pleurectomy 
in order to avoid bleeding complications and injury to intercostal 
nerves. If no bteb or bulla can be visualized, resection of the 
apex of the lung is recommended in order to reduce late recur- 
rence. There is increasing evidence in the literature that VATS 
seems to offer similar long-term results as conventional surgery 
in the surgical treatment of pneumothorax (5, 20, 22, 26). 
Lung volume reduction surgery: VATS is an excellent ool 
to accomplish lung volume reduction surgery in selected pa- 
tients with severe heterogeneous lung emphysema (27). This ap- 
Fig. 4. Neurogenic tumors may be confounded with a thoracic menin- 
gocele (Figure) which should not be resected. 
proach is probably better tolerated than sternotomy in those pa- 
tients with very limited reserves, especially in the early postop- 
erative period, with better preservation of the chest wall integrity 
leading to better mobilizatiom coughing and clearance of secre- 
tion. We have performed unilateral VATS-LVRS in a consecu- 
tive series of 25 patients, with minimal morbidity and no re- 
quirement of reintubation, tracheotomy and prolonged ICU stay 
(9). 
Lung cancer: Early stage non-small cell hmg cancer is best 
dealt with Iobectomy or pneumonectomy and mediastinal lymph 
node dissection. Non-anatomical resections bear a 3 to 5 fold 
risk of local recurrence as compared to lobectolny, even in stage 
I disease (11), Formal mediastinal lymph node dissection does 
increase the accuracy of staging and eliminates the risk to leave 
disease behind which, since unrecognized, will inevitably lead 
to local recurrence and significant local complications (18). Sev- 
eral studies have demonstrated that lymph node dissection is not 
associated with a higher morbidity than sampling and one pro- 
spective trial has documented an overall survival advantage over 
sampling in selected patients (15). Although anatomical resec- 
tions may be performed by use of VATS, there is no evidence so 
far that mediastinal lymph node dissection is equally well per- 
formed than by conventional surgery. Marly centers believe that 
the balance between completeness of resection (including avoid- 
ance of pleural or chest wall seeding) and postoperative morbid- 
ity is not in favor to VATS as compared to conventional surgery 
for the treatment of lung cancer (7, 12, 16). 
Pulmonary metastases: VATS is useful in the management 
of patients with pulmonary metastasis. When a needle biopsy 
cannot be performed or if the biopsy fails to yield a diagnosis, 
VATS can obtain sufficient issue for analysis with a high de- 
gree of success. However, the role of VATS in potential thera- 
peutic resections is uncertain and needs to be clarified further. 
One of the strongest predictor regarding long-term survival after 
pulmonary metastasectomy is complete resection at operation 
(23). However, it has been demonstrated that VATS resection of 
lung metastases performed in the intention to remove all disease, 
wi!l leave behind gross disease in as much as 50% of the pa- 
tients, as found at conventional surgery following the VATS 
procedure (21 ). 
Med ias t ina J  d iseases 
Biopsy of mediastinM masses: VATS is an excellent option to 
access lesions of unknown origin in the posterior and inferior 
mediastinum not accessible by mediastinoscopy or anterior 
mediastinotomy (8). Lesions within the aorto-pulmonary win- 
dow may also be accessed by VATS. In addition, all mediastinal 
]ylnph nodes (N2) are theoretically accessible at VATS. sub- 
carinal nodes being more easily accessed from the rigt]t side. 
However, lesions situated along the tracheobronchial tree are 
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Fig. 5. Bilateral simultaneous symphateclomy b  use of a urological cvsto-resectoscope introduced through a single thoracoport in the axilla 
with the patient in the supine position (a). The sympathetic chain is then coagulated over the ribs I I-V (b). 
preferably accessed by transbronchial needle aspiration or me- 
diastinoscopy. Mediastinoscopy remains the surgical procedure 
of choice for accessing levels 2, 4, 7 especially for staging of 
lung cancer since mediastinoscopy allows the simultaneous ex- 
ploration of both sides without requiring double lumen 
intubation, and with lesser morbidity than thoracoscopy (8). Al- 
though masses in the anterior mediastinal compartment may also 
be accessed by VATS we do not feel comfortable to use this 
technique for this purpose: 60% of these lesions are malignant 
and most frequently related to lymphoma, thymoma or germ cell 
tumors. Every effort should be made to keep the disease con- 
fined within the anterior compartment during biopsy in order to 
prevent contamination of the pleural cavity. Many centers prefer 
CT-guided tru-cut biopsy or anterior mediastinotomy for this 
purpose (8). 
Thymectomy is indicated in the treatment of myasthenia gra- 
vis and thymoma. Both indications require a complete removal 
of the entire thymic gland (which has demonstrated great indi- 
vidual variation regarding its anatomical configuration) and a 
complete clearance of the entire mediastinal fat from phrenic 
nerve to phrenic nerve (4). This is required to remove ectopic 
thymic tissue which is found outside the thymic capsule in up to 
70 to 80 % of patients. We feet that his goat is best accom- 
plished through a median sternotomy. There is some evidence in 
the literature that less extensive resection may result in interior 
long-term results especially regarding remission rates after 
thymectomy for myasthenia gravis. To improve the cosmetical 
results in women we have performed a submammar incision fol- 
lowed by epifascial dissection and a longitudinal sternotomy, 
with excellent results in 25 patients. If a less invasive approach 
is desired, transcervical thymectomy is usually preferred over 
VATS since satisfactory results can be obtained with lesser mor- 
bidity than with VATS-thymectomy (6). 
Resection of mediastinaI cysts and neurogenic tumors: 
Mediastinal cysts may arise from malformations of the ventral 
and dorsal foregut, resulting in bronchogenic and enteric cysts, 
respectively. Excision is usua!ly recommended r.oprevent com- 
plications such as infections or compression of adjacent struc- 
tures, and malignant degeneration (1, 13). VATS is well-suited 
in this respect if resection is anticipated. Lymphangioma orcysts 
arising from the thoracic duct, however, are better approached 
by conventional thoracotomy or by a hemiclamshell incision in 
order to achieve complete xcision. Neurogenic tumors are fre- 
quently situated in the paravertebral groove, arising from the 
sympathetic chain or the intercostal nerves. They are usually be- 
nign in adults and can be well excised by VATS provided that 
there is no extension into the spinal channel (dumbbell tumors) 
which must be excluded preoperatively by CT or MRI (Fig. 3). 
Large neurogenic tumors in patients with known Reckling- 
hausen disease hould be approached by conventional surgery 
since these tumors have usually undergone malignant degenera- 
tion. Neurogenic tumors in the pteural dome should only be ap- 
proached by VATS if a preoperative MRI has excluded adja- 
cency to the brachial plexus, otherwise these lesions must be dis- 
sected by an experienced plexus surgeon through a supra- 
clavicular approach. Finally, neurogenic tumors may be con- 
founded with a thoracic meningocele which should not be ex- 
cised (Fig. 4). 
Symphatectomy: Thoracic symphatectomy is indicated in 
impending finger gangrene due to arterial insufficiency not ame- 
nable to vascular econstruction and helps to prevent or mini- 
mize tissue loss (25). However, it is not indicated in Raynaud's 
phenomenon due to the high recurrence rate observed after a 
short period of time in this situation. Hyperhydrosis palmaris 
and erythrophobia re other indications for symphatectomy 
which will result in surprisingly gratifying and long-lasting re- 
sults (14). We and others use a cysto-resectoscope introduced 
through a single thoracoport in the axilla behind the pectoralis 
major muscle and coagulate the sympathetic chain over the ribs 
I1 to V (Fig. 5). This procedure can be performed bilaterally dur- 
ing the same operation with the patient in the supine position. 
There were no complications observed in our 63 patients oper- 
ated by this technique, with good results being observed in all 
patients. Therefore, we do not feel that excision of the sympa- 
thetic chain is necessary which requires a full lateral position 
and 3 thoracoports on each side. 
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